Up-regulation of endothelial nitric oxide synthase by cytochrome P450 arachidonic acid epoxygenase BM3F87V

被引:0
作者
Wang, H [1 ]
Lin, L [1 ]
Lu, ZY [1 ]
Wang, DW [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med,Div Cardiol, Wuhan 430030, Peoples R China
关键词
endothelium-derived hyperpolarizing factor; 14,15-epoxyeicosatrienoic acid; endothelial nitric oxide synthase; endothelial cells; BM(3)F87V;
D O I
暂无
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Cytochrome P450 (CYP)-dependent metabolites of arachidonic acid, epoxyeicosatrienoic acids (EETs), have been suggested to be an endothelium-derived hyperpolarizing factor (EDHF). However, the interaction or relation between EDHF and endothelial nitric oxide synthase (eNOS) is still to be elucidated. In the present study, the regulation of eNOS by endogenous EDHF is examined. The cytochrome P450 epoxygenase BM(3)F87V is cloned into the mammalian expression vector pCB(6). Cultured bovine aortic endothelial cells (BAECs) less than 4 passages are used and transfected with BM(3)F87V. The effects of endogenous EETs result from BM(3)F87V transfection on eNOS are assessed in the endothelial cells by Western blot and Northern blot, and eNOS activity is also measured by the conversion of L-arginine to L-citrulline. Compared to transfection with the empty pCB(6) vector, transfection of BAECs with BM(3)F87V significantly elevates the levels of eNOS protein expression, which is markedly inhibited by treatment with CYP inhibitor 17-ODYA. BM(3)F87V transfection also elevates the eNOS mRNA level and increases the eNOS activity. This study suggests that EDHF up-regutates eNOS gene expression.
引用
收藏
页码:598 / 602
页数:5
相关论文
共 23 条
[1]   Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor [J].
Bauersachs, J ;
Popp, R ;
Hecker, M ;
Sauer, E ;
Fleming, I ;
Busse, R .
CIRCULATION, 1996, 94 (12) :3341-3347
[2]   Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[3]  
Cannon RO, 1998, CLIN CHEM, V44, P1809
[4]   CYTOCHROME-P450 AND THE ARACHIDONATE CASCADE [J].
CAPDEVILA, JH ;
FALCK, JR ;
ESTABROOK, RW .
FASEB JOURNAL, 1992, 6 (02) :731-736
[5]   Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor [J].
Chen, JK ;
Wang, DW ;
Falck, JR ;
Capdevila, J ;
Harris, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4764-4769
[6]   ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION - BEYOND NITRIC-OXIDE AND CYCLIC-GMP [J].
COHEN, RA ;
VANHOUTTE, PM .
CIRCULATION, 1995, 92 (11) :3337-3349
[7]  
FITZPATRICK FA, 1989, PHARMACOL REV, V40, P229
[8]   Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries:: Role of a cytochrome P450 metabolite [J].
Gebremedhin, D ;
Harder, DR ;
Pratt, PF ;
Campbell, WB .
JOURNAL OF VASCULAR RESEARCH, 1998, 35 (04) :274-284
[9]   An active site substitution, F87V, converts cytochrome p450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase [J].
GrahamLorence, S ;
Truan, G ;
Peterson, JA ;
Falck, JR ;
Wei, SZ ;
Helvig, C ;
Capdevila, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :1127-1135
[10]   ROLE OF CYTOCHROME-P-450 ENZYMES AND METABOLITES OF ARACHIDONIC-ACID IN THE CONTROL OF VASCULAR TONE [J].
HARDER, DR ;
CAMPBELL, WB ;
ROMAN, RJ .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (02) :79-92